# E12A Principles for Clinical Evaluation of New Antihypertensive Drugs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e12a-principles-for-clinical-evaluation-of-new-antihypertensive-drugs/a715b1f0-1946-46b1-8a7f-cd01a428224d

> FDA guidance document: E12A Principles for Clinical Evaluation of New Antihypertensive Drugs. Issue date: August 09, 2000. Get complete insights and analysis.

---

## Details

- Title: E12A Principles for Clinical Evaluation of New Antihypertensive Drugs
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2000-08-09
- Last Changed: 2020-04-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2000-D-0785">FDA-2000-D-0785</a>

## Related Documents

- [E6(R3) Good Clinical Practice: Annex 2](https://www.globalkeysolutions.net/guidances/guidance-document/e6r3-good-clinical-practice-annex-2/8cba2156-b613-4d5b-9a03-bb5b0bc681c1)
- [M15 General Principles for Model-Informed Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/m15-general-principles-for-model-informed-drug-development/0c262249-637c-4377-ac7f-9fc2fa0ab688)
- [M5International Conference on Harmonisation; Draft Guidance on M5 Data Elements and Standards for Drug Dictionaries](https://www.globalkeysolutions.net/guidances/guidance-document/m5international-conference-on-harmonisation-draft-guidance-on-m5-data-elements-and-standards-for-drug-dictionaries/d4c223eb-7ce8-43b0-9cf7-93a7d505c695)